USPTO trademark

SERAVUE

Under examinationUSPTOWord markClass 5Class 9Class 42

"SERAVUE" is a word mark owned by ImCare Biotech, Inc., filed at the USPTO on September 4, 2026. It is under examination and covers classes 5, 9 and 42.

Get this data via the API
Official USPTO record
SERAVUE trademark as filed
As filed with the USPTO
Status
Under examination
Since September 4, 2026
Filed
September 4, 2026
Registered
Not yet
Expires
Not recorded
Application no.
50090913
Registration no.
Not yet
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
3 classes
Ownership

Who owns SERAVUE

The owner and representative on file with the office.

Owner

ImCare Biotech, Inc.

Doylestown, United States

Representative

Mike McArthur

Haynes and Boone, LLP

Goods and services

What the mark covers

The products and services SERAVUE is filed for, grouped by Nice class.

  • Diagnostic reagents for medical use in in vitro diagnosis; Medical diagnostic reagents for use in in vitro diagnosis of liver cancer; Medical diagnostic reagents for use in detection and surveillance of liver cancer; Diagnostic biomarker reagents for medical purposes; Diagnostic reagents for medical use; Diagnostic test reagents for medical use; Diagnostic reagents for medical purposes; Diagnostic test reagents for medical purposes; Reagents for use in diagnostic tests for medical purposes; Biological reagents for medical purposes; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, liver cancer; Diagnostic kits comprising diagnostic agents, preparations and substances for medical use; Diagnostic agents, preparations and substances for medical purposes; Clinical medical reagents; Medical diagnostic reagents; Diagnostic chemical reagents for medical purposes; Chemical reagents for medical purposes

  • Downloadable computer software for use in medical diagnostics; Downloadable computer software for analyzing medical data; Downloadable medical software for analysis and interpretation of clinical diagnostic data; Downloadable medical software for analyzing biomarker data for use in medical diagnostics; Downloadable medical software for generating diagnostic reports; Downloadable computer application software for mobile phones and tablet computers, namely, software for integration, analysis, management, and exchange of clinical laboratory and diagnostic data, calculating diagnostic risk scores, longitudinal tracking of patient clinical data, and generating diagnostic reports; Downloadable software in the nature of a mobile application for integration, analysis, management, and exchange of clinical laboratory and diagnostic data, calculating diagnostic risk scores, longitudinal tracking of patient clinical data, and generating diagnostic reports

  • Software as a service (SAAS) services featuring software for analysis and interpretation of clinical diagnostic data; Software as a service (SAAS) services featuring software for calculating diagnostic risk scores; Software as a service (SAAS) services featuring software for statistical analysis of clinical diagnostic data; Software as a service (SAAS) services featuring software for longitudinal tracking and analysis of patient clinical data; Software as a service (SAAS) services featuring software for generating diagnostic reports; Software as a service (SAAS) services featuring software for integration, transmission, and exchange of clinical laboratory and diagnostic data; Providing on-line non-downloadable software using artificial intelligence (AI) for analysis and interpretation of clinical diagnostic data and diagnostic risk scores

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Application filing receipt mailed
  2. New application entered
FAQ

About SERAVUE

Who owns the trademark "SERAVUE"?

The USPTO trademark "SERAVUE" (application 50090913) is owned by ImCare Biotech, Inc.

What is the status of "SERAVUE"?

Its status at the USPTO is: under examination.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull SERAVUE and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_01a071ae-90d4-755d-8abc-35d55c368c31
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_01a071ae-90d4-755d-8abc-35d55c368c31",
  "object": "trademark",
  "mark_text": "SERAVUE",
  "status": {
    "primary": "pending",
    "stage": "examining"
  },
  "office_code": "US",
  "application_number": "50090913",
  "filing_date": "2026-09-04",
  "nice_classes": [
    5,
    9,
    42
  ],
  "owners": [
    {
      "name": "ImCare Biotech, Inc.",
      "entity_id": null
    }
  ]
}